UMS United Medical Systems International AG / Key word(s): Quarter Results 12.11.2010 09:04 --------------------------------------------------------------------------- Hamburg, November 12, 2010 - UMS United Medical Systems International AG (UMS/ISIN DE0005493654) increased its operating revenues in the third quarter of 2010, once again topping the prior quarter and the same quarter a year ago. Consolidated revenues totaled EUR10.1 million, which corresponds to a 15% year-on-year improvement (Q3 2009: EUR8.8 million). At constant exchange rates, the increase was 4%. Consolidated EBIT for the third quarter of this year came to EUR3.5 million, compared with EUR3.0 million the previous period. On an exchange rate adjusted basis, the increase in EBIT was 5%. Earnings per share stood at EUR0.16, after EUR0.13 in the third quarter of 2009. That put UMS AG's earnings per share for the first nine months of the year at EUR0.46, following EUR0.40 for the same period a year ago. The UMS Group's two most important segments varied in their performance. In the Urology segment, the total number of treatments as well as the average number of treatments per treatment day increased further, with revenues and earnings far ahead of the previous year's figures. The UMS Group's performance in the area of laser treatments was particularly robust. In contrast, the Company was not able to reach its growth targets in the Gynecology segment. Demand in the United States receded in the wake of the country's stubbornly high unemployment rate, with many affected individuals and families also losing their health insurance after a carry-over period. The average number of stereotactic breast biopsies performed per day fell from the year before. Overall, UMS AG is confirming its earnings guidance of EUR0.55 to EUR0.65 per share for 2010. The complete report for the third quarter of 2010 is available in German and English on UMS AG's website at www.umsag.com in PDF format. About UMS AG UMS International AG is a provider of innovative healthcare delivery concepts in the growth segment of high-tech medicine. UMS pioneered the mobile deployment of high-class medical systems and markets a comprehensive range of full-service solutions for hospitals and specialists. The forward-looking concepts include complete services for the customer, covering everything from system management to the provision of trained application specialists. The UMS Group currently has around 200 employees worldwide and serves over 600 customers. Contact Wiebke Budwasch, Phone: (040) 500 177-00, Fax: (040) 500 177-77, E-mail: investor@umsag.com 12.11.2010 Dissemination of a Corporate News, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: UMS United Medical Systems International AG Borsteler Chaussee 53 22453 Hamburg Deutschland Phone: +49 (0)40 - 500 177 - 00 Fax: +49 (0)40 - 500 177 - 77 E-mail: investor@umsag.com Internet: www.umsag.com ISIN: DE0005493654 WKN: 549365 Listed: Regulierter Markt in Frankfurt (Prime Standard); Freiverkehr in Hamburg, München, Düsseldorf, Berlin, Stuttgart End of Announcement DGAP News-Service ---------------------------------------------------------------------------
DGAP-News: UMS AG: Earnings per share up from 13 to 16 euro cents in the third quarter of 2010
| Source: EQS Group AG